DK484685D0 - Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse - Google Patents

Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse

Info

Publication number
DK484685D0
DK484685D0 DK484685A DK484685A DK484685D0 DK 484685 D0 DK484685 D0 DK 484685D0 DK 484685 A DK484685 A DK 484685A DK 484685 A DK484685 A DK 484685A DK 484685 D0 DK484685 D0 DK 484685D0
Authority
DK
Denmark
Prior art keywords
compositions
micellular
tumors
human
target
Prior art date
Application number
DK484685A
Other languages
English (en)
Other versions
DK484685A (da
DK167907B1 (da
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Original Assignee
Vestar Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vestar Research Inc filed Critical Vestar Research Inc
Publication of DK484685D0 publication Critical patent/DK484685D0/da
Publication of DK484685A publication Critical patent/DK484685A/da
Application granted granted Critical
Publication of DK167907B1 publication Critical patent/DK167907B1/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK484685A 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker DK167907B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67420184A 1984-11-23 1984-11-23
US67420184 1984-11-23

Publications (3)

Publication Number Publication Date
DK484685D0 true DK484685D0 (da) 1985-10-22
DK484685A DK484685A (da) 1986-05-24
DK167907B1 DK167907B1 (da) 1994-01-03

Family

ID=24705713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484685A DK167907B1 (da) 1984-11-23 1985-10-22 Anvendelse af micellulaere partikler til fremstilling af farmaceutiske praeparater til maalrettet tilfoersel til tumorer i mennesker

Country Status (8)

Country Link
EP (1) EP0182131B1 (da)
JP (1) JPS61158933A (da)
KR (1) KR860004315A (da)
AT (1) ATE70456T1 (da)
CA (1) CA1267840A (da)
DE (1) DE3584948D1 (da)
DK (1) DK167907B1 (da)
IE (1) IE58124B1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710371A1 (de) * 1987-03-28 1988-10-13 Dornier Medizintechnik Zerstoerung von krankhaft veraenderten gewebezellen
NZ275054A (en) * 1993-11-08 1997-04-24 Peptide Delivery Systems Pty L Diagnosing atherosclerosis or coronary artery disease using labelled composition which mimics essential features of an exogenous lipoprotein
US6537518B1 (en) 1994-01-21 2003-03-25 Sirtex Medical Limited Particulate material
JP3770906B2 (ja) * 1994-01-21 2006-04-26 シルテックス、メディカル、リミテッド 粒状材料
AUPP032097A0 (en) * 1997-11-11 1997-12-04 Peptide Delivery Systems Pty Ltd Improved labelled diagnostic compositions and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992513A (en) * 1975-01-07 1976-11-16 Atomic Energy Of Canada Limited Labelled phospholipid material colloidially dispersed and sized to localize at preselected organs
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances

Also Published As

Publication number Publication date
KR860004315A (ko) 1986-06-20
IE58124B1 (en) 1993-07-14
DE3584948D1 (de) 1992-01-30
CA1267840A (en) 1990-04-17
EP0182131B1 (en) 1991-12-18
DK484685A (da) 1986-05-24
IE852601L (en) 1986-05-23
EP0182131A1 (en) 1986-05-28
JPS61158933A (ja) 1986-07-18
JPH0582369B2 (da) 1993-11-18
ATE70456T1 (de) 1992-01-15
DK167907B1 (da) 1994-01-03

Similar Documents

Publication Publication Date Title
AU587232B2 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles and methods for using same for tumor therapy
HK160895A (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
DE3670498D1 (de) Abs-zusammensetzungen mit trimodaler teilchenverteilung und herstellungsverfahren.
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
IL87421A (en) Pharmaceutical compositions containing 5-amino (or substituted amino) - 1,2,3-triazoles
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
IT8320435A0 (it) Composizione per il trattamento dell'acne.
DK484685A (da) Micellulaere partikelkompositioner til maalrettet tilfoersel til tumorer i mennesker og kompositionernes anvendelse
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
SE8107181L (sv) Dental komposition
DK484585D0 (da) Micellulaere partikelkompositioner, hvori er indkapslet billedtagende og kemoterapeutiske midler for tumorer, og kompositionernes anvendelse
GB2098478B (en) Propioibacteria preparations for use in the treatment of tumours
ES8607217A1 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
DE3563047D1 (en) Bis(4-isocyanatophenoxy) alkanes optionally methyl-substituted in position 3, method for their preparation and their use in the preparation of polyurethanes
IT1208798B (it) Procedimento per la produzione din 4 3 amminopropil amminobutil 2 2diidrossi etanammide e suo impiegocome intermedio nella sintesi dicomposti antitumorali
EP0147707A3 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IT8522027A0 (it) Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
IL78269A (en) Dermatological therapeutical compositions containing imidazolidinylurea derivative

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired